Surgery is the primary treatment for soft tissue sarcoma. It aims to remove cancerous tumors from tissues like muscle and fat. The type of surgery needed depends on the tumor’s characteristics, ...

Extraskeletal osteosarcoma is a rare and aggressive malignant tumour arising in soft tissues, distinguished by its production of osteoid without any direct attachment to the skeleton. Although it ...

Novel biomarkers like GDF15 and OPN show promise in diagnosing and prognosticating uterine sarcoma, potentially enabling early identification and tailored therapy. Blood-based markers such as NLR and ...

Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate Cancer This retrospective ...

Combined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trials indicate that pathologic complete ...

Project LiBRha aims to improve pediatric STS diagnosis and treatment through comprehensive molecular testing and liquid biopsy integration. The initiative involves 18 centers and partnerships with the ...

Soft tissue sarcomas are a group of rare cancers that can occur in almost any part of the body and develop in tissues like muscle, fat, and nerves. The most common types are leiomyosarcoma, ...

New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...

For most types of STS and for earlier stages of sarcoma, the treatment is usually similar. People may have surgery alone, or radiation therapy or chemotherapy in addition to surgery. Treatment may ...

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, ...